Cystic Tumor of the Atrioventricular Node: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 18: Line 18:
There is no established system for the staging of [malignancy name].
There is no established system for the staging of [malignancy name].


==Pathophysiology==
The exact pathogenesis of [disease name] is not fully understood.


OR
CTAVN are rare. They are choristomatous lesions composed of ectopic gland located in the atrioventricular node and the atrial septum.
 
Other midline defects are seen in 10% of the patients.


It is thought that [disease name] is the result of / is mediated by / is produced by / is caused by either [hypothesis 1], [hypothesis 2], or [hypothesis 3].
Considering their location, congenital heart block is a typical manifestation.


OR


[Pathogen name] is usually transmitted via the [transmission route] route to the human host.
The most common initial manifestation is sudden death.Most CTAVN are diagnosed incidentally at autopsy.


OR
There are a few case reports of successfully resected atrioventricular nodal tumors.


Following transmission/ingestion, the [pathogen] uses the [entry site] to invade the [cell name] cell.


OR
==Pathophysiology==




[Disease or malignancy name] arises from [cell name]s, which are [cell type] cells that are normally involved in [function of cells].
[Disease or malignancy name] arises from [cell name]s, which are [cell type] cells that are normally involved in [function of cells].


OR


The progression to [disease name] usually involves the [molecular pathway].
On gross pathology, small multiocular cysts are characteristic findings of CTAVN.The tumor may be invisible from the endocardial surface of the heart. Therefore, sectioning through the infero-medial tricuspid annulus might be required.<ref name="pmid26838113">{{cite journal| author=Miller DV| title=Cardiac Tumors. | journal=Surg Pathol Clin | year= 2012 | volume= 5 | issue= 2 | pages= 453-83 | pmid=26838113 | doi=10.1016/j.path.2012.04.007 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26838113  }}</ref>
 
OR


The pathophysiology of [disease/malignancy] depends on the histological subtype.
On microscopic histopathological analysis, solid cell nests and cystic structures lined by flattened cuboidal or squamous epithelium mixed with rare neuroendocrine cells are characteristic findings of CTAVN.


==Causes==
==Causes==
Line 62: Line 57:


==Differentiating Cystic Tumor of the Atrioventricular Tumor from Other Diseases==
==Differentiating Cystic Tumor of the Atrioventricular Tumor from Other Diseases==
Considering the location and histopathologic  
Considering the location and histopathologic <br />
<br />


==Epidemiology and Demographics==
==Epidemiology and Demographics==
Line 146: Line 140:


===Laboratory Findings===
===Laboratory Findings===
An elevated/reduced concentration of serum/blood/urinary/CSF/other [lab test] is diagnostic of [disease name].


OR


Laboratory findings consistent with the diagnosis of [disease name] include [abnormal test 1], [abnormal test 2], and [abnormal test 3].


OR
The cysts contain a clear to mucoid material and mucinous, ciliated, goblet and transitional type cells may also be present in the lining (Fig. 29). The cells express CK7, but not CK20, and also stain positive for EMA and CEA. Miller


[Test] is usually normal among patients with [disease name].
OR
Some patients with [disease name] may have elevated/reduced concentration of [test], which is usually suggestive of [progression/complication].
OR
There are no diagnostic laboratory findings associated with [disease name].


Cystic and solid cell nests with mixed, but predominantly squamous-like cells. miller Histologically: benign tumors and lined by flattened cuboidal or squamous epithelium. (WHO)
<br />
===Electrocardiogram===
===Electrocardiogram===
There are no ECG findings associated with [disease name].
There are no ECG findings associated with [disease name].
Line 235: Line 219:
==Treatment==
==Treatment==
===Medical Therapy===
===Medical Therapy===
Because of their ominous prognosis, surgical excision (requiring lifelong pacemaker placement) is recommended if these are detected on clinical imaging. Miller
There is no treatment for [disease name]; the mainstay of therapy is supportive care.
There is no treatment for [disease name]; the mainstay of therapy is supportive care.



Revision as of 15:28, 8 July 2019

WikiDoc Resources for Cystic Tumor of the Atrioventricular Node

Articles

Most recent articles on Cystic Tumor of the Atrioventricular Node

Most cited articles on Cystic Tumor of the Atrioventricular Node

Review articles on Cystic Tumor of the Atrioventricular Node

Articles on Cystic Tumor of the Atrioventricular Node in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Cystic Tumor of the Atrioventricular Node

Images of Cystic Tumor of the Atrioventricular Node

Photos of Cystic Tumor of the Atrioventricular Node

Podcasts & MP3s on Cystic Tumor of the Atrioventricular Node

Videos on Cystic Tumor of the Atrioventricular Node

Evidence Based Medicine

Cochrane Collaboration on Cystic Tumor of the Atrioventricular Node

Bandolier on Cystic Tumor of the Atrioventricular Node

TRIP on Cystic Tumor of the Atrioventricular Node

Clinical Trials

Ongoing Trials on Cystic Tumor of the Atrioventricular Node at Clinical Trials.gov

Trial results on Cystic Tumor of the Atrioventricular Node

Clinical Trials on Cystic Tumor of the Atrioventricular Node at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Cystic Tumor of the Atrioventricular Node

NICE Guidance on Cystic Tumor of the Atrioventricular Node

NHS PRODIGY Guidance

FDA on Cystic Tumor of the Atrioventricular Node

CDC on Cystic Tumor of the Atrioventricular Node

Books

Books on Cystic Tumor of the Atrioventricular Node

News

Cystic Tumor of the Atrioventricular Node in the news

Be alerted to news on Cystic Tumor of the Atrioventricular Node

News trends on Cystic Tumor of the Atrioventricular Node

Commentary

Blogs on Cystic Tumor of the Atrioventricular Node

Definitions

Definitions of Cystic Tumor of the Atrioventricular Node

Patient Resources / Community

Patient resources on Cystic Tumor of the Atrioventricular Node

Discussion groups on Cystic Tumor of the Atrioventricular Node

Patient Handouts on Cystic Tumor of the Atrioventricular Node

Directions to Hospitals Treating Cystic Tumor of the Atrioventricular Node

Risk calculators and risk factors for Cystic Tumor of the Atrioventricular Node

Healthcare Provider Resources

Symptoms of Cystic Tumor of the Atrioventricular Node

Causes & Risk Factors for Cystic Tumor of the Atrioventricular Node

Diagnostic studies for Cystic Tumor of the Atrioventricular Node

Treatment of Cystic Tumor of the Atrioventricular Node

Continuing Medical Education (CME)

CME Programs on Cystic Tumor of the Atrioventricular Node

International

Cystic Tumor of the Atrioventricular Node en Espanol

Cystic Tumor of the Atrioventricular Node en Francais

Business

Cystic Tumor of the Atrioventricular Node in the Marketplace

Patents on Cystic Tumor of the Atrioventricular Node

Experimental / Informatics

List of terms related to Cystic Tumor of the Atrioventricular Node

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mandana Chitsazan, M.D. [2]

Synonyms and keywords: Mesothelioma of the atrioventricular node

Overview

Historical Perspective

Cystic tumor of the atrioventricular (AV) node was first reported by Armstrong and Mönckeberg in 1911. [1]

Classification

There is no established system for the classification of [disease name].

OR

There is no established system for the staging of [malignancy name].


CTAVN are rare. They are choristomatous lesions composed of ectopic gland located in the atrioventricular node and the atrial septum.

Other midline defects are seen in 10% of the patients.

Considering their location, congenital heart block is a typical manifestation.


The most common initial manifestation is sudden death.Most CTAVN are diagnosed incidentally at autopsy.

There are a few case reports of successfully resected atrioventricular nodal tumors.


Pathophysiology

[Disease or malignancy name] arises from [cell name]s, which are [cell type] cells that are normally involved in [function of cells].


On gross pathology, small multiocular cysts are characteristic findings of CTAVN.The tumor may be invisible from the endocardial surface of the heart. Therefore, sectioning through the infero-medial tricuspid annulus might be required.[2]

On microscopic histopathological analysis, solid cell nests and cystic structures lined by flattened cuboidal or squamous epithelium mixed with rare neuroendocrine cells are characteristic findings of CTAVN.

Causes

Disease name] may be caused by [cause1], [cause2], or [cause3].

OR

Common causes of [disease] include [cause1], [cause2], and [cause3].

OR

The most common cause of [disease name] is [cause 1]. Less common causes of [disease name] include [cause 2], [cause 3], and [cause 4].

OR

The cause of [disease name] has not been identified. To review risk factors for the development of [disease name], click here.

Differentiating Cystic Tumor of the Atrioventricular Tumor from Other Diseases

Considering the location and histopathologic

Epidemiology and Demographics

CTANV is commonly diagnosed in the fourth decade of life. [3]

The female to male ratio is approximately 3 to 1 [4].

Risk Factors

There are no established risk factors for [disease name].

OR

The most potent risk factor in the development of [disease name] is [risk factor 1]. Other risk factors include [risk factor 2], [risk factor 3], and [risk factor 4].

OR

Common risk factors in the development of [disease name] include [risk factor 1], [risk factor 2], [risk factor 3], and [risk factor 4].

OR

Common risk factors in the development of [disease name] may be occupational, environmental, genetic, and viral.

Screening

There is insufficient evidence to recommend routine screening for [disease/malignancy].

OR

According to the [guideline name], screening for [disease name] is not recommended.

OR

According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with [condition 1], [condition 2], and [condition 3].

Natural History, Complications, and Prognosis

If left untreated, [#]% of patients with [disease name] may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].

OR

Common complications of [disease name] include [complication 1], [complication 2], and [complication 3].

OR

Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [#]%.

Diagnosis

Diagnostic Study of Choice

The diagnosis of [disease name] is made when at least [number] of the following [number] diagnostic criteria are met: [criterion 1], [criterion 2], [criterion 3], and [criterion 4].

OR

The diagnosis of [disease name] is based on the [criteria name] criteria, which include [criterion 1], [criterion 2], and [criterion 3].

OR

The diagnosis of [disease name] is based on the [definition name] definition, which includes [criterion 1], [criterion 2], and [criterion 3].

OR

There are no established criteria for the diagnosis of [disease name].

History and Symptoms

The majority of patients with [disease name] are asymptomatic.

OR

The hallmark of [disease name] is [finding]. A positive history of [finding 1] and [finding 2] is suggestive of [disease name]. The most common symptoms of [disease name] include [symptom 1], [symptom 2], and [symptom 3]. Common symptoms of [disease] include [symptom 1], [symptom 2], and [symptom 3]. Less common symptoms of [disease name] include [symptom 1], [symptom 2], and [symptom 3].

Physical Examination

Patients with [disease name] usually appear [general appearance]. Physical examination of patients with [disease name] is usually remarkable for [finding 1], [finding 2], and [finding 3].

OR

Common physical examination findings of [disease name] include [finding 1], [finding 2], and [finding 3].

OR

The presence of [finding(s)] on physical examination is diagnostic of [disease name].

OR

The presence of [finding(s)] on physical examination is highly suggestive of [disease name].

Laboratory Findings

The cysts contain a clear to mucoid material and mucinous, ciliated, goblet and transitional type cells may also be present in the lining (Fig. 29). The cells express CK7, but not CK20, and also stain positive for EMA and CEA. Miller


Cystic and solid cell nests with mixed, but predominantly squamous-like cells. miller Histologically: benign tumors and lined by flattened cuboidal or squamous epithelium. (WHO)

Electrocardiogram

There are no ECG findings associated with [disease name].

OR

An ECG may be helpful in the diagnosis of [disease name]. Findings on an ECG suggestive of/diagnostic of [disease name] include [finding 1], [finding 2], and [finding 3].

X-ray

There are no x-ray findings associated with [disease name].

OR

An x-ray may be helpful in the diagnosis of [disease name]. Findings on an x-ray suggestive of/diagnostic of [disease name] include [finding 1], [finding 2], and [finding 3].

OR

There are no x-ray findings associated with [disease name]. However, an x-ray may be helpful in the diagnosis of complications of [disease name], which include [complication 1], [complication 2], and [complication 3].

Echocardiography or Ultrasound

There are no echocardiography/ultrasound findings associated with [disease name].

OR

Echocardiography/ultrasound may be helpful in the diagnosis of [disease name]. Findings on an echocardiography/ultrasound suggestive of/diagnostic of [disease name] include [finding 1], [finding 2], and [finding 3].

OR

There are no echocardiography/ultrasound findings associated with [disease name]. However, an echocardiography/ultrasound may be helpful in the diagnosis of complications of [disease name], which include [complication 1], [complication 2], and [complication 3].

CT scan

There are no CT scan findings associated with [disease name].

OR

[Location] CT scan may be helpful in the diagnosis of [disease name]. Findings on CT scan suggestive of/diagnostic of [disease name] include [finding 1], [finding 2], and [finding 3].

OR

There are no CT scan findings associated with [disease name]. However, a CT scan may be helpful in the diagnosis of complications of [disease name], which include [complication 1], [complication 2], and [complication 3].

MRI

There are no MRI findings associated with [disease name].

OR

[Location] MRI may be helpful in the diagnosis of [disease name]. Findings on MRI suggestive of/diagnostic of [disease name] include [finding 1], [finding 2], and [finding 3].

OR

There are no MRI findings associated with [disease name]. However, a MRI may be helpful in the diagnosis of complications of [disease name], which include [complication 1], [complication 2], and [complication 3].

Other Imaging Findings

There are no other imaging findings associated with [disease name].

OR

[Imaging modality] may be helpful in the diagnosis of [disease name]. Findings on an [imaging modality] suggestive of/diagnostic of [disease name] include [finding 1], [finding 2], and [finding 3].

Other Diagnostic Studies

There are no other diagnostic studies associated with [disease name].

OR

[Diagnostic study] may be helpful in the diagnosis of [disease name]. Findings suggestive of/diagnostic of [disease name] include [finding 1], [finding 2], and [finding 3].

OR

Other diagnostic studies for [disease name] include [diagnostic study 1], which demonstrates [finding 1], [finding 2], and [finding 3], and [diagnostic study 2], which demonstrates [finding 1], [finding 2], and [finding 3].

Treatment

Medical Therapy

Because of their ominous prognosis, surgical excision (requiring lifelong pacemaker placement) is recommended if these are detected on clinical imaging. Miller


There is no treatment for [disease name]; the mainstay of therapy is supportive care.

OR

Supportive therapy for [disease name] includes [therapy 1], [therapy 2], and [therapy 3].

OR

The majority of cases of [disease name] are self-limited and require only supportive care.

OR

[Disease name] is a medical emergency and requires prompt treatment.

OR

The mainstay of treatment for [disease name] is [therapy].

OR   The optimal therapy for [malignancy name] depends on the stage at diagnosis.

OR

[Therapy] is recommended among all patients who develop [disease name].

OR

Pharmacologic medical therapy is recommended among patients with [disease subclass 1], [disease subclass 2], and [disease subclass 3].

OR

Pharmacologic medical therapies for [disease name] include (either) [therapy 1], [therapy 2], and/or [therapy 3].

OR

Empiric therapy for [disease name] depends on [disease factor 1] and [disease factor 2].

OR

Patients with [disease subclass 1] are treated with [therapy 1], whereas patients with [disease subclass 2] are treated with [therapy 2].

Surgery

Surgical intervention is not recommended for the management of [disease name].

OR

Surgery is not the first-line treatment option for patients with [disease name]. Surgery is usually reserved for patients with either [indication 1], [indication 2], and [indication 3]

OR

The mainstay of treatment for [disease name] is medical therapy. Surgery is usually reserved for patients with either [indication 1], [indication 2], and/or [indication 3].

OR

The feasibility of surgery depends on the stage of [malignancy] at diagnosis.

OR

Surgery is the mainstay of treatment for [disease or malignancy].

Primary Prevention

There are no established measures for the primary prevention of [disease name].

OR

There are no available vaccines against [disease name].

OR

Effective measures for the primary prevention of [disease name] include [measure1], [measure2], and [measure3].

OR

[Vaccine name] vaccine is recommended for [patient population] to prevent [disease name]. Other primary prevention strategies include [strategy 1], [strategy 2], and [strategy 3].

Secondary Prevention

There are no established measures for the secondary prevention of [disease name].

OR

Effective measures for the secondary prevention of [disease name] include [strategy 1], [strategy 2], and [strategy 3].

References

  1. Armstrong H, Mönckeberg JG (1911). "Herzblock, bedingt durch primären Herztumor, bei einem 5 jährigen Kinde". Dtsch Arch Klin Med. 102: 144–146.
  2. Miller DV (2012). "Cardiac Tumors". Surg Pathol Clin. 5 (2): 453–83. doi:10.1016/j.path.2012.04.007. PMID 26838113.
  3. Burke A, Tavora F (2016). "The 2015 WHO Classification of Tumors of the Heart and Pericardium". J Thorac Oncol. 11 (4): 441–52. doi:10.1016/j.jtho.2015.11.009. PMID 26725181.
  4. Burke A, Tavora F (2016). "The 2015 WHO Classification of Tumors of the Heart and Pericardium". J Thorac Oncol. 11 (4): 441–52. doi:10.1016/j.jtho.2015.11.009. PMID 26725181.


Template:WikiDoc Sources